Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-06

Clinical Trial Update: Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating valproic acid in ambulant adults with spinal muscular atrophy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALPROIC ACID (Valproic acid)

Snippet

Sponsor: University of Utah | Conditions: Spinal Muscular Atrophy | Phase 2 | Status: COMPLETED